Ravi Kasiappan is a Senior Scientist-II specializing in Oncology Discovery at AbbVie, with a robust background in preclinical research as a Scientist II at Aragen Bioscience, Inc. Previous roles include Scientist at SRI International and Research Scientist positions at both UCSF Medical Center/CSIR-CFTRI and Texas A&M University. Ravi Kasiappan holds a Doctor of Philosophy (Ph.D.) in Biochemistry and Molecular Biology from the University of Madras.
March, 2022 - present